Skip to main content

Coming Up - Next Month in GT

Premium

Don’t miss these features in the April issue:

Attack on Cancer
In this special issue of Genome Technology, we’ll focus heavily on how the integrated biology arsenal is taking aim at all varieties of cancer, looking at the ways our many technology categories are playing vital roles. From proteomics to bioinformatics, from microarrays to RNAi, from pharmacogenomics to epigenetics, scientists from all avenues of integrated biology are working together in groundbreaking ways to understand, diagnose, and eventually defeat this rampant killer.

 

Inside the FDA
The FDA has taken center stage for many pharma and even academic researchers in this field. We’ll look at what the agency’s guidelines mean for you, show how they’re affecting the field, and introduce you to the newest FDA honchos who are heading up these initiatives.

 

Systems biology roundtable
In an attempt to reach some kind of consensus, our experts discuss the basics of systems biology.

 

 

The Scan

Call to Look Again

More than a dozen researchers penned a letter in Science saying a previous investigation into the origin of SARS-CoV-2 did not give theories equal consideration.

Not Always Trusted

In a new poll, slightly more than half of US adults have a great deal or quite a lot of trust in the Centers for Disease Control and Prevention, the Hill reports.

Identified Decades Later

A genetic genealogy approach has identified "Christy Crystal Creek," the New York Times reports.

Science Papers Report on Splicing Enhancer, Point of Care Test for Sexual Transmitted Disease

In Science this week: a novel RNA structural element that acts as a splicing enhancer, and more.